![](https://www.diabetesnews.com/wp-content/uploads/2012/04/stem-cell1-150x150.jpg)
The FDA has granted fast track designation to VX-880, which is a human stem cell-derived therapy for patients with type 1 diabetes. This islet cell therapy is designed to regulate glucose levels by restoring a patient’s pancreatic islet cell function, including insulin production. Read more